Fintel reports that on February 27, 2026, William Blair upgraded their outlook for Biodesix (NasdaqGM:BDSX) from Market Perform to Outperform.
Analyst Price Forecast Suggests 116.24% Upside
As of February 25, 2026, the average one-year price target for Biodesix is $33.15/share. The forecasts range from a low of $20.20 to a high of $42.00. The average price target represents an increase of 116.24% from its latest reported closing price of $15.33 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Biodesix is 94MM, an increase of 16.68%. The projected annual non-GAAP EPS is -1.22.
What is the Fund Sentiment?
There are 31 funds or institutions reporting positions in Biodesix. This is an decrease of 5 owner(s) or 13.89% in the last quarter. Average portfolio weight of all funds dedicated to BDSX is 0.02%, an increase of 45.65%. Total shares owned by institutions increased in the last three months by 4.79% to 1,342K shares. 
The put/call ratio of BDSX is 0.10, indicating a bullish outlook.
What are Other Shareholders Doing?
Telemark Asset Management holds 328K shares representing 4.12% ownership of the company. In its prior filing, the firm reported owning 414K shares , representing a decrease of 26.33%. The firm decreased its portfolio allocation in BDSX by 24.97% over the last quarter.
Standard Life Aberdeen holds 262K shares representing 3.30% ownership of the company.
Monashee Investment Management holds 112K shares representing 1.41% ownership of the company. In its prior filing, the firm reported owning 100K shares , representing an increase of 10.99%.
Perceptive Advisors holds 109K shares representing 1.37% ownership of the company. In its prior filing, the firm reported owning 0K shares , representing an increase of 100.00%.
Gsa Capital Partners Llp holds 64K shares representing 0.81% ownership of the company. In its prior filing, the firm reported owning 48K shares , representing an increase of 25.03%. The firm increased its portfolio allocation in BDSX by 23.98% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
